There are several therapeutic options for the management of PD, including the administration of levodopa, dopamine agonists, monoamine oxidase B (MAO-B) inhibitors, catechol-o-methyl transferase (COMT) inhibitors, and anticholinergic agents, among others [8,11,12] (Figure 1). The gene discussed is COMT; the disease is Parkinson disease.